Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA

Orphanet Journal of Rare Diseases

Volumn 9, Issue 1, 2014, Pages

  Lin, Hsiang Yu ^a,b,c,d   Chuang, Chih Kuang ^b,e,f   Chen, Ming Ren ^a,b,c   Chiu, Pao Chin ^g   Ke, Yu Yuan ^h   Niu, Dau Ming ^d,i   Tsai, Fuu Jen ^j   Hwu, Wuh Liang ^k   Lin, Ju Li ^l   Lin, Shuan Pei ^a,b,c,m  

^a MACKAY MEDICAL COLLEGE   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^f NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^g KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^j CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^k NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^l CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^m NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

more..

Author keywords

Clinical manifestations; Diagnosis; History; Management; Mucopolysaccharidosis IVA

Indexed keywords

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MUCOPOLYSACCHARIDOSIS IV; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84893643796     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-9-21     Document Type: Article

References (32)

1. The mucoplysaccharidoses. Neufeld EF, Muenzer J, The Metabolic and Molecular Bases of Inherited Disease New York: McGraw-Hill, Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, 8 2001 3421 3452
2. Neurochemical changes and therapeutical approaches in mucopolysaccharidoses. Chuang CK, Lin SP, Neurochemistry of Metabolic Diseases-Lysosomal storage diseases, phenylketouria and Canavan disease Trivandrum, India: Transworld Research Network, Sankar S, Michael A, Maheep B, 2007 1 20
3. Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review. Northover H, Cowie RA, Wraith JE, J Inherit Metab Dis 1996 19 357 365 10.1007/BF01799267 8803780 (Pubitemid 26185528)
4. International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. Montaño AM, Tomatsu S, Gottesman GS, Smith M, Orii T, J Inherit Metab Dis 2007 30 165 174 10.1007/s10545-007-0529-7 17347914 (Pubitemid 46487997)
5. Long Term Outcomes of a Phase 1/2, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of BMN 110 in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome). Hendriksz C, Vellodi A, Jones S, Takkele H, Lee S, Chesler S, et al. Mol Genet Metab 2012 105 35
6. Incidence of the mucopolysaccharidoses in Northern Ireland. Nelson J, Hum Genet 1997 101 355 358 10.1007/s004390050641 9439667 (Pubitemid 28197533)
7. Incidence of the mucopolysaccharidoses in Western Australia. Nelson J, Crowhurst J, Carey B, Greed L, Am J Med Genet A 2003 123A 310 313 10.1002/ajmg.a.20314 14608657 (Pubitemid 37464354)
8. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004. Lin HY, Lin SP, Chuang CK, Niu DM, Chen MR, Tsai FJ, et al. Am J Med Genet A 2009 149A 960 964 10.1002/ajmg.a.32781 19396827
9. Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA. Lee NH, Cho SY, Maeng SH, Jeon TY, Sohn YB, Kim SJ, et al. Korean J Pediatr 2012 55 430 437 10.3345/kjp.2012.55.11.430 23227063
10. The Morquio A Clinical Assessment Program: Baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Harmatz P, Mengel KE, Giugliani R, Valayannopoulos V, Lin SP, Parini R, et al. Mol Genet Metab 2013 109 54 61 10.1016/j.ymgme.2013.01.021 23452954
11. Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis. Chuang CK, Lin SP, Chung SF, Zhonghua Yi Xue Za Zhi (Taipei) 2001 64 15 22 11310367
12. New growth charts for Taiwanese children and adolescents based on World Health Organization standards and health-related physical fitness. Chen W, Chang MH, Pediatr Neonatol 2010 51 69 79 10.1016/S1875-9572(10)60014-9 20417456
13. Cardiovascular changes in mucopolysaccharidoses in Taiwan. Chen MR, Lin SP, Hwang HK, Yu CH, Acta Cardiol 2005 60 51 53 10.2143/AC.60.1.2005049 15779852 (Pubitemid 40824319)
14. Echocardiographic measurements in normal subjects from infancy to old age. Henry WL, Gardin JM, Ware JH, Circulation 1980 62 1054 1061 10.1161/01.CIR.62.5.1054 7418156 (Pubitemid 11225973)
15. Standardization of Spirometry, 1994 Update. American Thoracic Society, Am J Respir Crit Care Med 1995 152 1107 1136 7663792
16. Spirometry for health care providers, Global initiative for chronic obstructive lung disease (GOLD) Available at http://www.goldcopd.org/uploads/ users/files/GOLD-Spirometry-2010.pdf. (Data accessed: November 5, 2013)
17. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses-changes with age and treatment. Lin SP, Shih SC, Chuang CK, Lee KS, Chen MR, Niu DM, et al. Pediatr Pulmonol 2013 doi: 10.1002/ppul.22774
18. World Health Organization, WHO ear and hearing disorders survey protocol for a population-based survey of prevalence and causes of deafness and hearing impairment and other ear disorders 1999 Retrieved from http://whqlibdoc.who.int/ hq/1999/WHO-PBD-PDH-99.8 (1).pdf on November 5, 2013
19. Assessment of Bone Mineral Density by Dual Energy X-ray Absorptiometry in Patients with Mucopolysaccharidoses. Lin HY, Shih SC, Chuang CK, Chen MR, Niu DM, Lin SP, Orphanet J Rare Dis 2013 8 71 10.1186/1750-1172-8-71 23663302
20. Polysomnographic characteristics in patients with mucopolysaccharidoses. Lin HY, Chen MR, Lin CC, Chen CP, Lin DS, Chuang CK, et al. Pediatr Pulmonol 2010 45 1205 1212 10.1002/ppul.21309 20717914
21. Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS). Jones SA, Almássy Z, Beck M, Burt K, Clarke JT, Giugliani R, et al. J Inherit Metab Dis 2009 32 534 543 10.1007/s10545-009-1119-7 19597960
22. Airway changes in children with mucopolysaccharidoses. Shih SL, Lee YJ, Lin SP, Sheu CY, Blickman JG, Acta Radiol 2002 43 40 43 11972460
23. Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA. Hendriksz CJ, Al-Jawad M, Berger KI, Hawley SM, Lawrence R, Mc Ardle C, et al. J Inherit Metab Dis 2013 36 309 322 10.1007/s10545-012-9459-0 22358740
24. The oral health needs of children, adolescents and young adults affected by a mucopolysaccharide disorder. James A, Hendriksz CJ, Addison O, JIMD Rep 2012 2 51 58 23430854
25. Clinical utility of endurance measures for evaluation of treatment in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). McDonald A, Steiner R, Kuehl K, Turbeville S, J Pediatr Rehabil Med 2010 3 119 127 21791839
26. Standard reference for the six-minute-walk test in healthy children aged 7 to 16 years. Li AM, Yin J, Au JT, So HK, Tsang T, Wong E, et al. Am J Respir Crit Care Med 2007 176 174 180 10.1164/rccm.200607-883OC 17463419 (Pubitemid 47057854)
27. The 6-minute walk test: normal values for children of 4-11 years of age. Lammers AE, Hislop AA, Flynn Y, Haworth SG, Arch Dis Child 2008 93 464 468 10.1136/adc.2007.123653 17675356 (Pubitemid 352025761)
28. ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, Am J Respir Crit Care Med 2002 166 111 117 12091180
29. Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase. Harmatz P, Giugliani R, Schwartz IV, Guffon N, Teles EL, Miranda MC, et al. Mol Genet Metab 2008 94 469 475 10.1016/j.ymgme.2008.04.001 18502162
30. Corneal clouding in the genetic mucopolysaccharidoses: a cell culture study. Danes BS, Clin Genet 1973 4 1 7 4266264
31. Ocular manifestations in patients affected by Morquio syndrome (MPS IV). Couprie J, Denis P, Guffon N, Reynes N, Masset H, Beby F, J Fr Ophtalmol 2010 33 617 622 10.1016/j.jfo.2010.09.008 21051099
32. Phoniatric aspects of children with mucopolysaccharidosis. Schleier E, Streubel HG, Folia Phoniatr (Basel) 1976 28 65 72 10.1159/000264033 826465